Gene · 64115
Papers2,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VISTA: An Emerging Immune Checkpoint With Clinical Relevance Across Diverse Malignancies. | Immune Netw | 2025 | 41523141 | PubTator, text mining | PubMed |
| An immune checkpoint-based score is a prognostic marker in retrospective cohort study of patients with gastric cancer. | Transl Cancer Res | 2025 | 41510089 | PubTator, text mining | PubMed |
| Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cells. | Immunooncol Technol | 2025 | 41477575 | PubTator, text mining | PubMed |
| Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives. | Cancers (Basel) | 2025 | 41463268 | PubTator, text mining | PubMed |
| Immunophenotyping of septic shock patients with endotheliopathy: focus on monocyte subtypes and Immune regulatory molecules. | Front Immunol | 2025 | 41425588 | PubTator, text mining | PubMed |
| VISTA+ follicular regulatory T cells modulate the function of effector immune cells: implications for ovarian cancer immune escape. | Front Immunol | 2025 | 41394858 | PubTator, text mining | PubMed |
| Prostate tumor immune microenvironment changes following immunotherapy shared by patients who developed anti-tumor response or immune-related adverse events. | Oncoimmunology | 2025 | 41378786 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| RPA1, RFC1, and POLE Expression in Clear Cell Renal Cell Carcinoma: Immune and Clinical Relevance. | Anticancer Res | 2025 | 41318151 | PubTator, text mining | PubMed |
| Increased Immunohistochemical Expression of Stimulator of Interferon Genes (STING) in Renal Cancer with Venous Tumor Thrombus Is Associated with Worse Prognosis. | Biomedicines | 2025 | 41301766 | PubTator, text mining | PubMed |
| Immune cell-based transcriptomic Mendelian randomization and colocalization study on type 1 diabetes. | BMC Med | 2025 | 41299435 | PubTator, text mining | PubMed |
| Absent expression of VISTA and LAG-3 in mycosis fungoides. | Eur J Dermatol | 2025 | 41277658 | PubTator, text mining | PubMed |
| The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. | J Exp Clin Cancer Res | 2025 | 41233805 | PubTator, text mining | PubMed |
| Immune Dysregulation in Sepsis. A Narrative Review for the Clinicians. | Biomedicines | 2025 | 41153671 | PubTator, text mining | PubMed |
| Blebbisomes as autonomous communication hubs. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132497 | PubTator, text mining | PubMed |
| Dual targeting of TIGIT and VISTA in non-small-cell lung cancer immunotherapy. | EXCLI J | 2025 | 41103503 | PubTator, text mining | PubMed |
| The half-century odyssey of regulatory B cells: from Breg discovery to emerging frontiers. | Front Immunol | 2025 | 41080554 | PubTator, text mining | PubMed |
| VISTA expressed on tumor cells is regulated by m6A and influences immune microenvironment through STAT3/CCL22 in NSCLC. | J Transl Med | 2025 | 41039458 | PubTator, text mining | PubMed |
| Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy. | J Hematol Oncol | 2025 | 41013723 | PubTator, text mining | PubMed |
| The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part II: B7-1, B7-2, B7-H2, B7-H3, B7-H4, B7-H5 (VISTA), B7-H6 and B7-H7. | Postepy Dermatol Alergol | 2025 | 41001137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64115/papers?page=6